Clinical Trial

PLatform for Adaptive Trials In Perinatal UnitS - [Core Protocol]

Study acronym: PLATIPUS
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
PLATIPUS is an adaptive platform trial aimed at improving the health of infants born preterm (before 37 weeks' gestation). PLATIPUS will compare how different treatments and care provided to pregnant women and people at risk of preterm birth and infants born preterm affect infant health. The main questions PLATIPUS aims to answer are: 1. What effect/s do different treatments/care provided to pregnant women and people at risk of preterm birth have on the health of their infants? (Pregnancy domains) 2. What effect/s do different treatments/care given to infants born preterm have on their health ? (Neonatal domains). This registration record relates to the PLATIPUS Core (or 'master') protocol which provides guidance for the overall running of the trial. Additional appendices will outline the aims, questions, treatments, and activities for each separate research question (domain). Each Domain-Specific Appendix will be registered separately on ClinicalTrials.gov and will link to this record.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-06-13.
Trial Details
NCT Number NCT06461429
Lead Sponsor University of Melbourne
Collaborators: University of Auckland, New Zealand, Monash University, The University of Western Australia, La Trobe University, The University of New South Wales, University of Tasmania, Menzies School of Health Research, University of Adelaide, University of Sydney, Mater Medical Research Institute
Conditions Preterm Birth
Enrollment 100,000 participants
Start Date 2025-11-01
Primary Completion 2050-12-31 (estimated)
Study Completion 2050-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-06-13